289 related articles for article (PubMed ID: 23588232)
21. Anti-influenza virus effects of the aqueous extract from Mosla scabra.
Yu C; Yan Y; Wu X; Zhang B; Wang W; Wu Q
J Ethnopharmacol; 2010 Feb; 127(2):280-5. PubMed ID: 19914366
[TBL] [Abstract][Full Text] [Related]
22. Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.
Hong EH; Song JH; Shim A; Lee BR; Kwon BE; Song HH; Kim YJ; Chang SY; Jeong HG; Kim JG; Seo SU; Kim H; Kwon Y; Ko HJ
PLoS One; 2015; 10(6):e0131089. PubMed ID: 26098681
[TBL] [Abstract][Full Text] [Related]
23. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection.
Geng ZK; Li YQ; Cui QH; DU RK; Tian JZ
Chin J Nat Med; 2019 Sep; 17(9):650-662. PubMed ID: 31526500
[TBL] [Abstract][Full Text] [Related]
24. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
[TBL] [Abstract][Full Text] [Related]
25. The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus.
Kim HM; Kang YM; Ku KB; Park EH; Yum J; Kim JC; Jin SY; Lee JS; Kim HS; Seo SH
Virology; 2013 Sep; 444(1-2):394-403. PubMed ID: 23890814
[TBL] [Abstract][Full Text] [Related]
26. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.
Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT
J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290
[TBL] [Abstract][Full Text] [Related]
27. In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice.
Paukner S; Kimber S; Cumper C; Rea-Davies T; Sueiro Ballesteros L; Kirkham C; Hargreaves A; Gelone SP; Richards C; Wicha WW
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791439
[TBL] [Abstract][Full Text] [Related]
28. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.
Tanaka T; Kamiyama T; Daikoku T; Takahashi K; Nomura N; Kurokawa M; Shiraki K
Acta Virol; 2017; 61(1):48-55. PubMed ID: 28105854
[TBL] [Abstract][Full Text] [Related]
29. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
[TBL] [Abstract][Full Text] [Related]
30. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of homonojirimycin from Commelina communis (dayflower) on influenza virus infection in mice.
Zhang GB; Tian LQ; Li YM; Liao YF; Li J; Bing FH
Phytomedicine; 2013 Aug; 20(11):964-8. PubMed ID: 23746956
[TBL] [Abstract][Full Text] [Related]
33. [Effect of baicalin on in vivo anti-virus].
Chu ZY; Chu M; Teng Y
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2413-5. PubMed ID: 18257272
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.
Dimmock NJ; Dove BK; Meng B; Scott PD; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
Antiviral Res; 2012 Dec; 96(3):376-85. PubMed ID: 23041142
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
36. Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1.
Gao R; Du N; Liu D; Li Z; Zhu Y; Shu Y
Biochem Biophys Res Commun; 2013 Feb; 431(4):788-95. PubMed ID: 23333739
[TBL] [Abstract][Full Text] [Related]
37. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
Hamelin ME; Baz M; Bouhy X; Beaulieu E; Dubé K; Mallett C; Boivin G
Antivir Ther; 2011; 16(5):775-9. PubMed ID: 21817200
[TBL] [Abstract][Full Text] [Related]
38. Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.
Ohgitani E; Kita M; Mazda O; Imanishi J
Arch Virol; 2014 Feb; 159(2):267-75. PubMed ID: 23979178
[TBL] [Abstract][Full Text] [Related]
39. Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis.
Ji S; Li R; Wang Q; Miao WJ; Li ZW; Si LL; Qiao X; Yu SW; Zhou DM; Ye M
J Ethnopharmacol; 2015 Dec; 176():475-84. PubMed ID: 26578185
[TBL] [Abstract][Full Text] [Related]
40. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
